![](/img/cover-not-exists.png)
Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumors
Dahut, William L., Lakhani, Nehal J., Gulley, James L., Arlen, Philip M., Kohn, Elise C., Kotz, Herbert, McNally, Debbie, Parr, Allyson, Parr, Allyson, Nguyen, Diana, Yang, Sherry X., Steinberg, SethVolume:
5
Language:
english
Journal:
Cancer Biology & Therapy
DOI:
10.4161/cbt.5.1.2349
Date:
January, 2006
File:
PDF, 688 KB
english, 2006